FI874287A0 - Nya lymfokinpeptider. - Google Patents

Nya lymfokinpeptider.

Info

Publication number: FI874287A0
Authority: FI; Finland
Prior art keywords: lymphocinepeptider; nya; nya lymphocinepeptider
Prior art date: 1986-10-03

Application number

FI874287A

Other languages

English (en)

Other versions

FI874287L (fi

FI874287A7 (fi

Inventor

Karel Gerrit Odink

Roger Clerc

Nico Cerletti

Josef Brueggen

Lajos Tarcsay

Clemens Sorg

Walter Wiesendanger

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-03

Filing date

1987-09-30

Publication date

1987-09-30

1986-10-03 Priority claimed from GB868623850A external-priority patent/GB8623850D0/en

1986-11-27 Priority claimed from GB868628358A external-priority patent/GB8628358D0/en

1987-09-30 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1987-09-30 Publication of FI874287A0 publication Critical patent/FI874287A0/fi

1988-04-04 Publication of FI874287L publication Critical patent/FI874287L/fi

1988-04-04 Publication of FI874287A7 publication Critical patent/FI874287A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI874287A 1986-10-03 1987-09-30 Uudet lymfokiinipeptidit. FI874287A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868623850A GB8623850D0 (en)	1986-10-03	1986-10-03	Lymphokine related peptide
GB868628358A GB8628358D0 (en)	1986-11-27	1986-11-27	Lymphokine related peptides

Publications (3)

Publication Number	Publication Date
FI874287A0 true FI874287A0 (fi)	1987-09-30
FI874287L FI874287L (fi)	1988-04-04
FI874287A7 FI874287A7 (fi)	1988-04-04

Family

ID=26291377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI874287A FI874287A7 (fi)	1986-10-03	1987-09-30	Uudet lymfokiinipeptidit.

Country Status (11)

Country	Link
US (2)	US5350687A (fi)
EP (1)	EP0263072B1 (fi)
JP (1)	JPH09188698A (fi)
AU (1)	AU7930987A (fi)
DE (1)	DE3789413T2 (fi)
DK (1)	DK517787A (fi)
ES (1)	ES2052602T3 (fi)
FI (1)	FI874287A7 (fi)
IE (1)	IE61773B1 (fi)
NO (1)	NO874159L (fi)
PT (1)	PT85849B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2750604B1 (fr) *	1996-07-02	2002-09-20	Oreal	Heteromere liant l'acide arachidonique et son utilisation en cosmetique ou pharmacie
EP0463037A1 (en) *	1989-03-17	1992-01-02	Genetics Institute, Inc.	Human macrophage migration inhibitory factor
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines
JP2747839B2 (ja) *	1989-08-14	1998-05-06	花王株式会社	モノクローナル抗体
US5149544A (en) *	1989-11-13	1992-09-22	Research Corporation Technologies, Inc.	Method of inhibiting progenitor cell proliferation
SG66214A1 (en) *	1990-09-05	1999-07-20	Heart Research Inst Ltd	Novel chemotactic factor
CH685959A5 (de) *	1992-08-24	1995-11-15	Biomedicals Ag	Diagnostische Testpackung zur Bestimmung von Proteinen.
US6645493B1 (en) *	1993-05-17	2003-11-11	The Picower Institute For Medical Research	Composition containing anti-MIF antibody
US5776348A (en) *	1995-02-07	1998-07-07	Massachusetts Institute Of Technology	Mineral precipitation system and method for inhibiting mineral precipitate formation
US6653445B1 (en) *	1997-01-21	2003-11-25	Human Genome Sciences, Inc.	Human CCV polypeptides
WO2000018970A1 (fr)	1998-09-29	2000-04-06	Asahi Kasei Kabushiki Kaisha	Procede de commande de liberation de granules
DE69941627D1 (de) *	1998-11-05	2009-12-17	Univ Michigan	Für krebs
MY140679A (en)	2001-05-24	2010-01-15	Avanir Pharmaceuticals	Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
AU2003212246A1 (en) *	2002-02-15	2003-09-04	Johannes Roth	Method for diagnosis of inflammatory diseases using mrp8/mrp14
WO2004004770A1 (en) *	2002-07-05	2004-01-15	Universite Laval	Chemotactic factor inhibitor for modulating inflammatory reactions
TW200418829A (en)	2003-02-14	2004-10-01	Avanir Pharmaceutics	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US7361474B2 (en) *	2003-02-24	2008-04-22	United States Of America As Represented By The Department Of Veterans Affairs	Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
CA2520515C (en)	2003-03-28	2012-08-28	Universite Laval	S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
JP2007503388A (ja) *	2003-08-22	2007-02-22	アバニール・ファーマシューティカルズ	マクロファージ遊走阻止因子の阻害剤としての置換ナフチリジン誘導体、およびヒト疾患の治療におけるそれらの使用
CA2557503A1 (en) *	2004-02-25	2005-09-09	The United States Of America, As Represented By The Department Of Vetera Ns Affairs	Methods for diagnosing and treating bladder cancer
SE0400886D0 (sv) *	2004-04-02	2004-04-02	Amersham Biosciences Ab	Process of purification
EP1784216A4 (en) *	2004-07-13	2009-06-03	Univ Laval	S100 PROTEIN INHIBITOR FOR THE TREATMENT OF LEUKEMIA
EP2258866A3 (en)	2004-07-23	2011-03-30	AspenBio Pharma, Inc.	Methods and devices for diagnosis of appendicitis
US7659087B2 (en) *	2004-07-23	2010-02-09	Aspenbio Pharma, Inc.	Methods and devices for diagnosis of appendicitis
CA2600175A1 (en) *	2005-03-24	2006-03-20	Avanir Pharmaceuticals	Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) *	2006-03-21	2006-05-03	Novartis Ag	Organic compounds
EP3075867B1 (en) *	2008-09-03	2019-03-13	Quantumdx Group Limited	Sensing strategies and methods for nucleic acid detection using biosensors
JP6044900B2 (ja)	2011-05-20	2016-12-14	国立研究開発法人理化学研究所	生物材料用透明化試薬、及びその利用
AU2012320597C1 (en)	2011-10-07	2015-10-15	Baxalta GmbH	oxMIF as a diagnostic marker
EP3183581A1 (en) *	2014-08-22	2017-06-28	Baxalta GmbH	Detection of cho-mif contaminations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE230876C (fi) *
US4322274A (en) *	1980-08-28	1982-03-30	Wilson Gregory B	Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
GB2125047B (en)	1982-08-09	1986-02-19	Ciba Geigy Ag	Yeast hybrid vectors and their use for the production of polypeptides
GB8318754D0 (en) *	1983-07-11	1983-08-10	Fagerhol M K F	Human proteins anti-sera test kits
JPS6041697A (ja) *	1983-08-15	1985-03-05	Asahi Chem Ind Co Ltd	活性蛋白質誘導体の新規合成法
GR80965B (en)	1983-11-21	1985-03-20	Ciba Geigy Ag	Method for the preparation of protease inhibitors
FI86746C (fi)	1983-11-21	1992-10-12	Ciba Geigy Ag	Foerfarande foer framstaellning av maensklig vaevnads-plasminogenaktivator (tpa) med hjaelp av saccharomyces cerevisiae -jaest och i foerfarandet anvaenda hybridvektorer
JPH0672158B2 (ja)	1984-05-24	1994-09-14	チバ−ガイギ− アクチエンゲゼルシヤフト	精製されたヒトマクロファージ遊走阻止因子
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines

1987
- 1987-09-28 DE DE3789413T patent/DE3789413T2/de not_active Expired - Fee Related
- 1987-09-28 ES ES87810561T patent/ES2052602T3/es not_active Expired - Lifetime
- 1987-09-28 EP EP87810561A patent/EP0263072B1/en not_active Expired - Lifetime
- 1987-09-30 FI FI874287A patent/FI874287A7/fi not_active IP Right Cessation
- 1987-10-01 PT PT85849A patent/PT85849B/pt not_active IP Right Cessation
- 1987-10-02 IE IE264587A patent/IE61773B1/en not_active IP Right Cessation
- 1987-10-02 DK DK517787A patent/DK517787A/da not_active Application Discontinuation
- 1987-10-02 NO NO874159A patent/NO874159L/no unknown
- 1987-10-02 AU AU79309/87A patent/AU7930987A/en not_active Abandoned
1990
- 1990-11-21 US US07/617,485 patent/US5350687A/en not_active Expired - Fee Related
1995
- 1995-07-27 US US08/508,142 patent/US5702920A/en not_active Expired - Fee Related
1996
- 1996-12-18 JP JP8338746A patent/JPH09188698A/ja active Pending

Also Published As

Publication number	Publication date
FI874287L (fi)	1988-04-04
DE3789413D1 (de)	1994-04-28
FI874287A7 (fi)	1988-04-04
US5702920A (en)	1997-12-30
NO874159L (no)	1988-04-05
DE3789413T2 (de)	1994-07-28
PT85849B (pt)	1990-07-31
DK517787D0 (da)	1987-10-02
NO874159D0 (no)	1987-10-02
AU7930987A (en)	1988-05-19
ES2052602T3 (es)	1994-07-16
US5350687A (en)	1994-09-27
IE61773B1 (en)	1994-11-30
JPH09188698A (ja)	1997-07-22
IE872645L (en)	1988-04-03
PT85849A (en)	1987-11-01
EP0263072A3 (en)	1990-01-10
EP0263072B1 (en)	1994-03-23
DK517787A (da)	1988-04-04
EP0263072A2 (en)	1988-04-06

Publication	Publication Date	Title
FI870417A7 (fi)	1987-08-01	Nya fenol-tio-estrar anvaendbara saosom inhibitorer foer 5-lipoxygenas.
FI873977A0 (fi)	1987-09-14	Nya (1h-imidazol-1-ylmetyl) substituerande bensimidazolderivat.
FI873058A7 (fi)	1988-01-12	Foerfarande foer framstaellning av nya difosfonsyraderivat.
FI875096A7 (fi)	1988-05-22	Foerfarande foer framstaellning av nya substituerade alkandifosfonsyror.
FI872878L (fi)	1987-12-31	Foerfarande foer framstaellning av nya algininsyraestrar.
FI873339L (fi)	1988-02-02	Foerfarande foer framstaellning av nya difosfonsyraderivat.
FI874702L (fi)	1988-04-28	Foerfarande foer framstaellning av nya benzimidazolderivater.
FI874287A0 (fi)	1987-09-30	Nya lymfokinpeptider.
FI873704A0 (fi)	1987-08-26	Nya ksantinderivat.
FI874388A7 (fi)	1988-04-08	Foerfarande foer framstaellning av nya 5-alkylbensimidazoler.
FI875257A7 (fi)	1988-05-30	Foerfarande foer framstaellning av nya difosfonsyraderivat.
FI871406A0 (fi)	1987-03-31	Foerfarande foer framstaellning av nya aminosyraderivat.
FI870871A7 (fi)	1987-08-29	Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptidderivat.
FI875438A7 (fi)	1988-06-12	Foerfarande foer framstaellning av nya pyrrolobenzimidazoler.
FI871981A7 (fi)	1987-11-07	Nya dopamin- -hydroxylas-inhibitorer.
FI873193A0 (fi)	1987-07-20	Nya 18-fenylestranderivat.
FI873648A7 (fi)	1988-02-27	Nya 9-deazaguaniner.
FI873593A0 (fi)	1987-08-20	Nya applikationsformer foer -interferon.
FI883257A0 (fi)	1988-07-07	Nya peptider.
FI871445A7 (fi)	1987-10-05	Foerfarande foer framstaellning av nya spergualinderivat.
FI872571A0 (fi)	1987-06-09	Nya antracykliner.
FI875095A7 (fi)	1988-05-22	Foerfarande foer framstaellning av nya substituerade aminometandifosfonsyror.
FI872489A0 (fi)	1987-06-03	Foerfarande foer framstaellning av nya aralkylimidazolderivat.
FI871094A0 (fi)	1987-03-12	Nya monocykliska estrar.
FI893155A0 (fi)	1989-06-28	Nya foereningar.

Legal Events

Date	Code	Title	Description
2004-08-31	MM	Patent lapsed	Owner name: CIBA-GEIGY AG